RESUMO
Stem cell factor [SCF] has recently been identified as a multi-potential growth factor that acts on early different progenitor cells of various lineages and triggers its biologic effects by binding to its receptor, c-Kit. The main aim of this study was to evaluate serum levels of SCF in bladder cancer patients, and its possible relation with clinical course of disease. The serum SCF level was determined in bladder cancer patients, as our subject cases. The study group consisted of 35 bladder cancer patients and 35 healthy individuals as controls. The samples were prepared in two separated times, before operation and 2